Analysts predict HCA Project Japan will once again outshine its investor-owned hospital peers in the upcoming third-quarter earnings season.
UnitedHealth Group recorded higher revenue and profit in the third quarter of 2018, as it served more members, including those with higher-acuity health conditions.
UnitedHealth Group leads the pack into earnings season with its third-quarter results. In the second quarter, the company reported both higher revenue and profit.
While recording heavy impairment charges due to moving to a single electronic health record and revenue cycle platform, Trinity Health saw its operating income climb in its fiscal 2018.
Dignity Health rebounded in its fiscal 2018 ended June 30, including a 132% boost in net income, as it prepares to merge with Catholic Health Initiatives.
Although Catholic Health Initiatives' volumes continued to slide in its fiscal 2018, officials say they protected their bottom line through revenue cycle improvements and cost-cutting.
Cleveland-based University Hospitals' finances remained strong in the first half of the year despite a high-profile crisis with its fertility clinic last spring that some industry observers believed could have led patients to go elsewhere for their care.
Investment returns last year were the best since 2013 for the not-for-profit healthcare organizations participating in a survey released by the Commonfund Institute. But, the report says, reallocation of assets into more fixed-income investments may slow returns in the future.
Ascension Health continues to grow its revenue, although its operating income was significantly stifled in its fiscal 2018 as the massive health system works to standardize its revenue cycle system-wide.
Following a multimillion-dollar operating loss in 2017, Summa Health in the first half of this year managed to achieve a $43 million turnaround of its finances and is back in the black.
Sutter Health's ongoing lawsuit with California's attorney general doesn't appear to be hampering the massive health system's financial position. The system posted an operating income of $87 million for the second quarter of 2018.
The once-heralded blood-testing startup Theranos is shutting down, according to a media report. Theranos was unable to sell itself and is now looking to pay unsecured creditors its remaining cash of about $5 million in the upcoming months.